NGMDF OTC
NuGen Medical Devices Inc.
1W: +0.0%
1M: +0.0%
3M: -39.3%
YTD: -62.0%
1Y: -76.2%
3Y: -93.3%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$5M
+29.8% ▲
Capital Expenditures
$10K
-243.3% ▼
Free Cash Flow
-$5M
+29.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$6M
+1846.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$7M | -$6M | -$9M | -$5M |
| Depreciation & Amort. | $397K | $791K | $652K | $691K | $646K |
| Stock-Based Comp. | $162K | $1M | $432K | $1M | $95K |
| Change in Working Capital | $660K | -$228K | $604K | -$726K | -$340K |
| Other Non-Cash Items | $1M | $1M | $2M | $1M | $105K |
| Operating Cash Flow | -$1M | -$4M | -$2M | -$7M | -$5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6K | -$4K | -$1K | -$3K | -$10K |
| Acquisitions (Net) | $58K | $5K | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | -$50K | -$2K |
| Investing Cash Flow | $53K | $2K | -$1K | -$53K | -$12K |
| — Financing Activities — | |||||
| Net Debt Issuance | $727K | $75K | -$84K | -$871K | $10M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $242K | $0 | -$75K | $1M | $1M |
| Financing Cash Flow | $2M | $6M | $514K | $7M | $11M |
| Net Change in Cash | $274K | $1M | -$2M | $333K | $6M |
| Cash End of Period | $276K | $2M | $131K | $464K | $7M |
| Free Cash Flow | -$1M | -$4M | -$2M | -$7M | -$5M |